Stalled patient enrollment
Is your clinical study at risk? Let’s get it back on track. Together.
There are a number of reasons why a clinical study may run off course.
If you’re experiencing one or more of these red flags with your current provider, it’s time to contact Premier Research.
Inadequate patient retention
Insufficient coordination of vendors
Missed milestones in study start-up
Subpar tools and technology
Delays in data cleaning
Rescue studies can be challenging, and you need assurances that transitions will be smooth. Meet ASIST.
Premier Research understands the importance of defining operating procedures to guide the transition, and have mobilized resources whose sole focus is on supporting the process. Premier’s Advanced Study Integrity Services Team (ASIST) is dedicated to analyzing issues, defining strategies, and developing a recovery plan for at-risk studies, all driven by our documented SOPs.
Our rescue study experts stand ready to partner with you through:
- Assessing your trial’s status and the challenges you’re facing
- Identifying the issues standing in the way of success
- Developing a plan to put the project back on schedule
- Leveraging ePremier, our in house study management technology platform, to perform an assessment pre-transition and enable a seamless handover of responsibilities
- Making technical recommendations that address study-specific challenges
The best predictor of future success is previous success. See our rescue studies in action below.
PREMIER INSIGHT 283
Rescuing a Phase 1 Oncology Trial: Long-Standing Experience Saves Study Momentum
When a sponsor of a novel oncology therapy contacted Premier Research, they were more than a year into their study and experiencing many issues. Premier’s extensive history in transitioning studies, combined with our oncology expertise, came to the rescue and got the study back on track.
Site Selection, Manufacturing & Long-Term Follow-Up: Looming Challenges for a Rescue Phase 1/2 Gene Therapy Trial
This case study is based on Premier Research’s work operationalizing a rescue Phase 1/2 gene therapy trial involving localized administration of gene therapy using specialized equipment.